Literature DB >> 1895267

Hydroxyapatite crystals are a frequent finding in osteoarthritic synovial fluid, but are not related to increased concentrations of keratan sulfate or interleukin 1 beta.

G J Carroll1, R A Stuart, J A Armstrong, P D Breidahl, B A Laing.   

Abstract

Synovial fluid (SF) was obtained from 40 patients with varying grades of osteoarthritis (OA) of the knee and examined by transmission electron microscopy to ascertain how frequently hydroxyapatite crystals (HA) were present and whether they were related to disease severity or putative markers or promoters of cartilage resorption. HA crystals were conspicuous and abundant in specimens from 21 of the 40 patients studied. Patients in whom HA was present had significantly larger effusions (13.0 +/- 8.9 vs 8.7 +/- 6.1 ml, p less than 0.05). They also tended to have radiologically more severe disease (radiological grade: 2.91 +/- 0.92 vs 2.39 +/- 0.85, p = 0.056). No difference in keratan sulfate (KS) concentrations was observed. Moreover, despite the presence in some specimens of numerous free histiocytes which were actively phagocytosing HA aggregates, the concentrations of interleukin 1 beta (IL-1 beta), a monocyte product with cartilage and bone resorbing activity, were below the limit of detection (20 pg/ml). Our results confirm that HA crystals are a common finding in patients with OA of the knee and show that HA is associated with larger effusions, but not increased SF concentrations of cartilage proteoglycan substituents (KS) or IL-1 beta.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1895267

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Telomerase transduced osteoarthritis fibroblast-like synoviocytes display a distinct gene expression profile.

Authors:  Yubo Sun; David R Mauerhan; Gary S Firestein; Bryan J Loeffler; Edward N Hanley; Helen E Gruber
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

2.  Basic calcium phosphate crystals activate human osteoarthritic synovial fibroblasts and induce matrix metalloproteinase-13 (collagenase-3) in adult porcine articular chondrocytes.

Authors:  G M McCarthy; P R Westfall; I Masuda; P A Christopherson; H S Cheung; P G Mitchell
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 3.  Crystal-induced inflammation and cartilage degradation.

Authors:  G M McCarthy
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

Review 4.  Crystal deposition and osteoarthritis.

Authors:  N Olmez; H R Schumacher
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

Review 5.  Mechanisms of joint destruction, pain and disability in osteoarthritis.

Authors:  R S Pinals
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 6.  Counterpoint: Hydroxyapatite crystal deposition is not intimately involved in the pathogenesis and progression of human osteoarthritis.

Authors:  Kenneth P H Pritzker
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

7.  Calcium deposition in osteoarthritic meniscus and meniscal cell culture.

Authors:  Yubo Sun; David R Mauerhan; Patrick R Honeycutt; Jeffrey S Kneisl; H James Norton; Natalia Zinchenko; Edward N Hanley; Helen E Gruber
Journal:  Arthritis Res Ther       Date:  2010-03-30       Impact factor: 5.156

Review 8.  Hydroxyapatite deposition disease of the joint.

Authors:  Eamonn S Molloy; Geraldine M McCarthy
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

9.  Analysis of meniscal degeneration and meniscal gene expression.

Authors:  Yubo Sun; David R Mauerhan; Patrick R Honeycutt; Jeffrey S Kneisl; James H Norton; Edward N Hanley; Helen E Gruber
Journal:  BMC Musculoskelet Disord       Date:  2010-01-28       Impact factor: 2.362

10.  Phosphocitrate is potentially a disease-modifying drug for noncrystal-associated osteoarthritis.

Authors:  Yubo Sun; David R Mauerhan; Atiya M Franklin; James Norton; Edward N Hanley; Helen E Gruber
Journal:  Biomed Res Int       Date:  2013-02-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.